HWM
ELV icon

HighMark Wealth Management’s Elevance Health ELV Stock Holding History

HighMark Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26
Closed -$7K – 461
2020
Q3 		$7K Hold
26
– – 0.01% 269
2020
Q2 		$7K Buy
+26
New +$6.94K 0.01% 266
2020
Q1 		– Sell
-32
Closed -$9K – 366
2019
Q4 		$9K Buy
+32
New +$8.81K 0.01% 224

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighMark Wealth Management's ELV Position: Q4 2020 in Review

HighMark Wealth Management sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 26 shares — an estimated $7K sold.

HighMark Wealth Management first reported a position in ELV in Q4 2019 and held it in 3 quarters. The position peaked at $9K in Q4 2019. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • HighMark Wealth Management reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • HighMark Wealth Management sold 26 Elevance Health shares in Q4 2020, an estimated $7K.
  • HighMark Wealth Management first reported a position in Elevance Health in Q4 2019 and held it in 3 quarters.
  • HighMark Wealth Management's Elevance Health position peaked at $9K in Q4 2019.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on HighMark Wealth Management's 13F filing for Q4 2020, filed 27 Jan 2021.